| ²é¿´: 182 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
qilu_qi½ð³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
°ïæ·Òë ÓÐЧÆÚÖÁ2009Äê9ÔÂ20
|
||
| TollÑùÊÜÌåÐźŴ«µ¼ÔÚÆô¶¯»úÌåµÄ¹ÌÓÐÃâÒß·´Ó¦£¬Tϸ°ûµÄ»î»¯¡¢ÔöÖ³¡¢·Ö»¯ÖÐÆðµ½ÖØÒªµÄ×÷Óᣱ¾ÏîĿͨ¹ýʵʱ¶¨Á¿ PCR¡¢Á÷ʽϸ°ûÊõ¡¢ÒÔ¼°ÃâÒß×黯µÈ¼¼Êõ£¬ÊÔͼ֤ʵÍÂ̼ٵ¥°û¾ú¿ÉÄÜͨ¹ýÓ°ÏìTLRÊÜÌå¡¢TLR´«µ¼Í¾¾¶Ïà¹Ø·Ö×Ó¡¢¸ºÐÔµ÷½ÚÒò×Ó£¬ÒÔ¼°ÕâÒ»¹ý³ÌÖÐËùÉæ¼°µÄNF-¦ÊBͨ·£¬·¢»Ó×÷Óã¬Õâ¿ÉÄÜÊÇÉúÎïĤ¶Ô¹ÌÓÐÃâÒߺͻñµÃÐÔÃâÒßÄÍÊܵÄÖØÒª»úÖÆÖ®Ò»¡£¿ªÕ¹´ËÏîÑо¿ÓÐÍûΪÑÐÖÆÍ¨¹ý¸ÉԤϸ¾ú,´Ó¶ø´ó´ó½µµÍϸ¾úΣº¦µÄÐÂÐ͵Ŀ¹¾úÖÆ¼ÁÌṩаÐλ¡£ |
» ²ÂÄãϲ»¶
085600£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ12È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
283Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0703»¯Ñ§
ÒѾÓÐ11È˻ظ´
322Çóµ÷¼Á£ºÒ»Ö¾Ô¸ºþÄÏ´óѧ ²ÄÁÏÓ뻯¹¤£¨085600£©£¬ÒѹýÁù¼¶¡£
ÒѾÓÐ18È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ12È˻ظ´
298Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
jw227
ľ³æ (ÖøÃûдÊÖ)
¿ÎÌâ×鳤
- ·ÒëEPI: 2
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ¹ó±ö: 1.06
- ½ð±Ò: 3456.8
- ºì»¨: 1
- Ìû×Ó: 1674
- ÔÚÏß: 293.4Сʱ
- ³æºÅ: 236869
- ×¢²á: 2006-04-03
- ÐÔ±ð: MM
- רҵ: ÌìÈ»Óлú»¯Ñ§
¡ï
qilu_qi(½ð±Ò+1,VIP+0): 9-6 20:30
qilu_qi(½ð±Ò+1,VIP+0): 9-6 20:30
|
An important role of Toll-like Receptor signaling for starting the body's innate immune response in activation, proliferation and differentiation of T cell. Through techniques of real-time and quantitative PCR, flow cytometry, and immunohistochemistry, this project attempts to confirm that Pseudomonas aeruginosa play a role through influencing the TLR receptor, TLR pathway-related molecules, negative regulators, as well as the process of involved in NF-¦ÊB pathway. This may be one of important mechanisms of biofilm on innate immunity and acquired immunological tolerance. This study is expected to greatly reduce bacterial hazards and provide a new target site for new antimicrobial agents through the intervention to bacteria . |

2Â¥2009-09-06 12:42:59
qilu_qi
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 402.8
- É¢½ð: 1610
- ºì»¨: 9
- Ìû×Ó: 1618
- ÔÚÏß: 245.9Сʱ
- ³æºÅ: 823689
- ×¢²á: 2009-08-07
ÇóÖú·ÅÆú °ïæ·Òë ÓÐЧÆÚÖÁ2009Äê9ÔÂ20
|
°ïæ·Òë ÓÐЧÆÚÖÁ2009Äê9ÔÂ20 TollÑùÊÜÌåÐźŴ«µ¼ÔÚÆô¶¯»úÌåµÄ¹ÌÓÐÃâÒß·´Ó¦£¬Tϸ°ûµÄ»î»¯¡¢ÔöÖ³¡¢·Ö»¯ÖÐÆðµ½ÖØÒªµÄ×÷Óᣱ¾ÏîĿͨ¹ýʵʱ¶¨Á¿ PCR¡¢Á÷ʽϸ°ûÊõ¡¢ÒÔ¼°ÃâÒß×黯µÈ¼¼Êõ£¬ÊÔͼ֤ʵÍÂ̼ٵ¥°û¾ú¿ÉÄÜͨ¹ýÓ°ÏìTLRÊÜÌå¡¢TLR´«µ¼Í¾¾¶Ïà¹Ø·Ö×Ó¡¢¸ºÐÔµ÷½ÚÒò×Ó£¬ÒÔ¼°ÕâÒ»¹ý³ÌÖÐËùÉæ¼°µÄNF-¦ÊBͨ·£¬·¢»Ó×÷Óã¬Õâ¿ÉÄÜÊÇÉúÎïĤ¶Ô¹ÌÓÐÃâÒߺͻñµÃÐÔÃâÒßÄÍÊܵÄÖØÒª»úÖÆÖ®Ò»¡£¿ªÕ¹´ËÏîÑо¿ÓÐÍûΪÑÐÖÆÍ¨¹ý¸ÉԤϸ¾ú,´Ó¶ø´ó´ó½µµÍϸ¾úΣº¦µÄÐÂÐ͵Ŀ¹¾úÖÆ¼ÁÌṩаÐλ¡£ |
3Â¥2009-09-07 20:06:53














»Ø¸´´ËÂ¥